MASTALEX -MRSA, MODEL RST501— 510(k) K062864
Substantially EquivalentMast Group , Ltd.
FDA 510(k) clearance K062864 for MASTALEX -MRSA, MODEL RST501, Substantially Equivalent on 2006-10-18. Applicant: Mast Group , Ltd..
Clearance details
- Applicant
- Mast Group , Ltd.
- Product code
- Code MYI
- Advisory panel
- Microbiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Bootle, Merseyside, GB
Data sourced from openFDA. This site is unofficial and independent of the FDA.